# Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

> **NCT00030342** · PHASE1,PHASE2 · COMPLETED · sponsor: **St. Luke's Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Colorectal Cancer
- Kidney Cancer

## Interventions

- **BIOLOGICAL:** recombinant interferon alfa
- **BIOLOGICAL:** sargramostim
- **BIOLOGICAL:** therapeutic autologous lymphocytes
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00030342
- **Lead sponsor:** St. Luke's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2007-10
- **Final completion:** 2008-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030342, "Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00030342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*